These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 7819352

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Estimates of the timing of reductions in genital warts and high grade cervical intraepithelial neoplasia after onset of human papillomavirus (HPV) vaccination in the United States.
    Chesson HW, Ekwueme DU, Saraiya M, Dunne EF, Markowitz LE.
    Vaccine; 2013 Aug 20; 31(37):3899-905. PubMed ID: 23820080
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. [Value of screening for cervical intraepithelial neoplasia in women treated for adnexitis].
    Giraud JR, Coiffic J, Poulain P, Kérisit J.
    J Gynecol Obstet Biol Reprod (Paris); 1997 Aug 20; 26(8):798-803. PubMed ID: 9509320
    [Abstract] [Full Text] [Related]

  • 46. The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial.
    Cotton S, Sharp L, Little J, Cruickshank M, Seth R, Smart L, Duncan I, Harrild K, Neal K, Waugh N, Trial Of Management of Borderline and Other Low-grade Abnormal Smears Group.
    BJOG; 2010 May 20; 117(6):645-59. PubMed ID: 20374607
    [Abstract] [Full Text] [Related]

  • 47. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O, Kares S, Kujala P, Tirkkonen M, Vuento R, Kholová I, Luukkaala T, Osuala V, Mäenpää J.
    Acta Obstet Gynecol Scand; 2016 Nov 20; 95(11):1220-1227. PubMed ID: 27591407
    [Abstract] [Full Text] [Related]

  • 48. Evaluation of portable colposcopy and human papillomavirus testing for screening of cervical cancer in rural China.
    Newman H, Hu J, Li X, He J, Bradford L, Shan S, Wu X, Zhu B, Yang W, Fu B, Zhu B, Gao G.
    Int J Gynecol Cancer; 2019 Jan 20; 29(1):23-27. PubMed ID: 30640679
    [Abstract] [Full Text] [Related]

  • 49. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
    Dane C, Batmaz G, Dane B, Cetin A.
    Ann Diagn Pathol; 2009 Apr 20; 13(2):73-7. PubMed ID: 19302953
    [Abstract] [Full Text] [Related]

  • 50. Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: systematic reviews and economic evaluation.
    Peron M, Llewellyn A, Moe-Byrne T, Walker S, Walton M, Harden M, Palmer S, Simmonds M.
    Health Technol Assess; 2018 Sep 20; 22(54):1-260. PubMed ID: 30284968
    [Abstract] [Full Text] [Related]

  • 51. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ, Dai Y, Dang L, Kong LH, Zhang Y, Feng RM, Qiao YL, Lang JH.
    Zhonghua Zhong Liu Za Zhi; 2018 Oct 23; 40(10):764-771. PubMed ID: 30392341
    [Abstract] [Full Text] [Related]

  • 52. A comparison of the reliability of repeat cervical smears and colposcopy in patients with abnormal cervical cytology.
    Mayeaux EJ, Harper MB, Abreo F, Pope JB, Phillips GS.
    J Fam Pract; 1995 Jan 23; 40(1):57-62. PubMed ID: 7807039
    [Abstract] [Full Text] [Related]

  • 53. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
    Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjänen K, Favalli C.
    Eur J Gynaecol Oncol; 2004 Jan 23; 25(5):577-84. PubMed ID: 15493169
    [Abstract] [Full Text] [Related]

  • 54. Colposcopic analysis of genital human papillomavirus infections during an 8-year prospective follow-up.
    Ji HX, Yliskoski M, Väyrynen M, Hippeläinen M, Syrjänen S, Syrjänen K.
    Int J Gynaecol Obstet; 1991 Dec 23; 36(4):291-300. PubMed ID: 1684763
    [Abstract] [Full Text] [Related]

  • 55. [Clinical value of p16INK4a immunocytochemistry in cervical cancer screening].
    Song FB, Du H, Xiao AM, Wang C, Huang X, Yan PS, Liu ZH, Qu XF, Belinson JEROMEL, Wu RF.
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov 25; 55(11):784-790. PubMed ID: 33228350
    [Abstract] [Full Text] [Related]

  • 56. The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.
    Tidy JA, Lyon R, Ellis K, Macdonald M, Palmer JE.
    BJOG; 2020 Sep 25; 127(10):1260-1267. PubMed ID: 32279427
    [Abstract] [Full Text] [Related]

  • 57. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
    Flores Y, Shah K, Lazcano E, Hernández M, Bishai D, Ferris DG, Lörincz A, Hernández P, Salmerón J, Morelos HPV Study Collaborators.
    Salud Publica Mex; 2002 Sep 25; 44(4):335-44. PubMed ID: 12216521
    [Abstract] [Full Text] [Related]

  • 58. Adeno-associated virus infection and cervical neoplasia: is there a protective role against human papillomavirus-related carcinogenesis?
    Agorastos T, Chrisafi S, Lambropoulos AF, Mikos T, Constandinides TC, Schlehofer JR, Schlehofer B, Kotsis A, Bontis JN.
    Eur J Cancer Prev; 2008 Aug 25; 17(4):364-8. PubMed ID: 18562963
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.
    Bokan T, Ivanus U, Jerman T, Takac I, Arko D.
    Radiol Oncol; 2021 Jan 06; 55(2):187-195. PubMed ID: 33764704
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.